Peptidomimetic macrocycles
AssigneeAileron Therapeutics, Inc.
InventorsVincent GUERLAVAIS, Carl ELKIN, Huw M. NASH, Tomi K. SAWYER, Bradford J. GRAVES, Eric FEYFANT
Life of this patent
Estimating the term…
Loading patent…
AssigneeAileron Therapeutics, Inc.
InventorsVincent GUERLAVAIS, Carl ELKIN, Huw M. NASH, Tomi K. SAWYER, Bradford J. GRAVES, Eric FEYFANT
Estimating the term…
Provided herein are peptidomimetic macrocycles containing amino acid sequences with at least two modified amino acids that form an intramolecular cross-link that can help to stabilize a secondary structure of the amino acid sequence. Suitable sequences for stabilization include those with homology to the p53 protein. These sequences can bind to the MDM2 and/or MDMX proteins. Also provided herein are methods of using such macrocycles for the treatment of diseases and disorders, such as cancers or other disorders characterized by a low level or low activity of a p53 protein or high level of activity of a MDM2 and/or MDMX protein.
-102. (canceled)
A method for treating cancer, comprising administering to a subject with cancer a therapeutically effective amount of a pharmaceutical product comprising
A pharmaceutical product, comprising
A method for treating cancer, comprising administering to a subject with cancer a peptidomimetic macrocycle or pharmaceutically acceptable salt thereof comprising an amino acid sequence with at least about 90% sequence identity to an amino acid sequence selected from the group consisting of SEQ ID NOs:
Dependencies are inferred from the claim text.